A carregar...
Genetic variations associated with gemcitabine treatment outcome in pancreatic cancer
BACKGROUND: Pancreatic cancer is a rapidly fatal disease with gemcitabine remaining the first-line therapy. We performed a genotype–phenotype association study to identify biomarkers for predicting gemcitabine treatment outcome. MATERIALS AND METHODS: We selected the top 200 single nucleotide polymo...
Na minha lista:
| Publicado no: | Pharmacogenet Genomics |
|---|---|
| Main Authors: | , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Lippincott Williams & Wilkins
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5083195/ https://ncbi.nlm.nih.gov/pubmed/27749787 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/FPC.0000000000000241 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|